Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation
- PMID: 2672796
- DOI: 10.1016/s0272-6386(89)80066-6
Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
